Connecticut Innovations

What Connecticut Innovations does

Connecticut Innovations (CI) is the quasi-public venture capital arm of the State of Connecticut, founded in 1989 and headquartered at 470 James Street, New Haven. CI provides equity financing, venture debt, and ongoing operational support to early-stage technology companies based primarily in Connecticut, with a current portfolio of approximately 250 companies spanning biotech, IT, climate tech, and consumer packaged goods. The organization deploys capital across multiple thematic evergreen funds: the $200M Connecticut Bioscience Innovation Fund (CBIF), $100M ClimateTech Fund, $50M AI/Q Fund (AI/quantum/deep tech), $50M Future Fund (diversity-focused), alongside equity financing (up to $1.5M per round, max $7M per company), venture debt ($1M-$5M), pre-seed (up to $150K), and proof-of-concept ($50K-$100K) programs. CI also administers the state's Angel Investor Tax Credit Program (25% credit on $25K+ angel investments, capped at $5M annually) and the federally funded SSBCI Technical Assistance Program for socially and economically disadvantaged individuals and very small businesses.

CI's revenue model is fundamentally that of a fund manager and capital allocator rather than a product company: it generates proceeds through portfolio company exits and IPOs, and earns returns on equity and debt investments across its dedicated funds. In FY26 YTD (through Q3), CI invested $33.5M, leveraged $638.2M in outside capital, and generated $57.7M in proceeds, with $41M in Q2 FY26 alone driven by the $3.05B Halda Therapeutics acquisition by Johnson & Johnson. Recent notable exits also include the February 2026 Veradermics IPO ($256M raised on NYSE: MANE), and historically Alexion Pharmaceuticals, Biohaven, Arvinas, and Rallybio. Beyond capital, CI provides differentiated portfolio support through its Human Capital Services team (talent acquisition via contracted Bohan & Bradstreet, university recruiting, employer branding, compensation benchmarking), Science Park incubator wet-lab space in New Haven, the BioFacilities Fund (supporting 300,000+ sq ft of lab infrastructure), and network access to Connecticut's 40 universities, venture investors, and government leaders.

Distribution is direct-to-founder through a stringent due-diligence application process, supplemented by university partnership channels (UConn, Yale, Tsai CITY), the VentureClash global venture challenge, the annual CI Talent Fair, and ecosystem intermediaries. Go-to-market is hybrid: a sales-led direct outreach core (typical check size $500K-$1M per round at seed/Series A), augmented by event-driven sourcing (VentureClash), community-led ecosystem activation (CTNext subsidiary), and channel partnerships with executive recruiters and accelerators (Mission BioCapital Platinum Program). CI operates as a not-for-profit state instrumentality rather than a privately held VC firm, with no external shareholders and oversight via a state-appointed board.

Name

Connecticut Innovations

Legal name

Connecticut Innovations

Website

http://www.ctinnovations.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

51–100 employees

Short description

Connecticut Innovations is the quasi-public venture capital arm of the State of Connecticut, deploying equity, debt, and thematic fund capital across biotech, AI/quantum, climate tech, and IT to approximately 250 early-stage Connecticut-based portfolio companies, supplemented by talent acquisition support and state tax credit program administration.

Ownership category

akta.pro rank

Product category

Venture Capital / Investment Management

NAICS

Portfolio Management and Investment Advice (523940), Other Financial Vehicles (525990)

SIC

Investment Advice (6282)

akta.pro primary industry

Early-Stage Venture Capital (Series A/B) (FSANAAAB)

akta.pro secondary industries

Late-Stage Venture Capital (Series C+) (FSANAAAC), Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD), Venture Capital Fund-of-Funds / Multi-Manager Platforms (FSANAAAJ)

Keywords

• Venture capital investing
• Early-stage equity financing
• Venture debt financing
• Biotech investment funds
• Climate tech investing

Headquarters

HQ city

Rocky Hill

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Investment Returns (Capital Gains): Generates revenue through proceeds from portfolio company exits and IPOs; e.g., approximately $41 million in venture proceeds in Q2 FY26 largely driven by the Halda Therapeutics acquisition by Johnson & Johnson for $3.05 billion. CI generated $57.7 million in proceeds FY26 YTD.
2. Equity Investment Income: CI deploys capital across multiple dedicated funds (Equity Financing, CBIF, ClimateTech Fund, AI/Q Fund, Future Fund, Venture Debt, Pre-Seed, Proof-of-Concept) and earns returns on those investments as companies grow and exit. FY26 YTD: $33.5 million invested, $638.2 million in outside capital leveraged.
3. Angel Investor Tax Credit Program Administration: CI administers the state's Angel Investor Tax Credit Program, which provides a 25% Connecticut state income tax credit for angels investing at least $25,000 in qualifying businesses, with a maximum annual cap of $5 million on $20 million of investments. Program runs July 1 to June 30 and expires June 30, 2028.

Pricing tiers

Go-to-market motion4 records

Distribution channels5 records

Marketing channels9 records

Core offering

Connecticut Innovations deploys venture capital (equity and debt) into Connecticut-based early-stage technology companies through multiple specialized evergreen funds, including the Connecticut Bioscience Innovation Fund ($200M), ClimateTech Fund ($100M), AI/Q Fund ($50M), Future Fund ($50M), Equity Financing, Venture Debt, Pre-Seed, and Proof-of-Concept programs. Investments range from $50K (Proof-of-Concept) up to $7M per company (Equity Financing) and $1M-$5M (Venture Debt), with typical seed and Series A rounds between $500K and $1.5M per company. CI complements capital with operational support including Human Capital Services talent acquisition, mentoring, board building, and access to its network of 40 Connecticut universities.

Product overview

Connecticut Innovations (CI) is a venture capital firm (not a software product company), offering a platform of investment funds and portfolio support services rather than a single unified product. Its core offering consists of capital programs (Equity Financing, Venture Debt, Pre-Seed, Proof-of-Concept, Angel Investor Tax Credit, SSBCI Technical Assistance) wrapped around four thematic evergreen funds: the $50M Future Fund (diversity-focused), the $50M AI/Q Fund (AI/quantum/deep tech), the $100M ClimateTech Fund, and the $200M Connecticut Bioscience Innovation Fund (CBIF). These capital programs are complemented by Human Capital Services (HCS) talent acquisition support, the VentureClash global venture challenge, and access to a network of executives-in-residence and mentors across a portfolio of nearly 250 companies.

Differentiator

Problem solved

Functional benefit

Brands

• VentureClash: Global venture challenge/investment program operated by CI (Lauren Carmody manages marketing for VentureClash along with CI and Tidal River).
• Tidal River
• CTNext

Products and services

• AI/Q Fund A $50 million fund investing in high-potential companies at the intersection of artificial intelligence, quantum computing, and deep tech, targeting scalable commercial AI and quantum ventures. Targeted at founders and executives of AI, quantum computing, and deep tech companies.
• ClimateTech Fund A $100 million fund that invests capital and strategic support in early-stage and growth companies across advanced materials, built environment, carbon removal, circular economy, energy, food/agriculture, and mobility, typically investing $150,000 to $5 million per company with required co-investment. Targeted at founders of climate tech startups.
• Future Fund A $50 million fund supporting early-stage, venture-backable, tech-enabled startups that champion diversity, with diversity at the board and executive level considered crucial. Targeted at founders of diverse-led startups.
• Connecticut Bioscience Innovation Fund (CBIF) A $200 million evergreen fund focused on bioscience investment in Connecticut, supporting pre-seed to growth-stage bioscience companies. Targeted at founders of bioscience and biotech companies in Connecticut.
• Equity Financing CI invests up to $1.5 million per round, typically up to a maximum of $7 million in any one company, including strategic guidance, introductions to valuable partners, and ongoing support. Targeted at Connecticut-based early-stage technology companies seeking venture capital.
• Venture Debt CI's Venture Debt Fund helps early-stage and later-stage businesses obtain debt financing that falls outside traditional bank lending guidelines, offering debt solutions ranging from $1 million to $5 million. Targeted at early-stage and later-stage businesses needing non-bank debt financing.
• Pre-Seed Investment CI's Pre-Seed investment provides up to $150,000 to help early-stage companies grow, including mentoring, resources, and introductions to connections to turn ideas into commercially viable businesses. Targeted at the earliest-stage Connecticut-based technology companies.
• Proof-of-Concept Fund CI invests $50,000-$100,000 per company through the Proof-of-Concept Fund, selecting the most promising companies that meet its investment criteria. Targeted at very early-stage companies with promising concepts.
• Angel Investor Tax Credit Program A state-administered program giving accredited angel investors a 25 percent credit against Connecticut's state income tax when they invest at least $25,000 in qualifying businesses, with a maximum annual tax credit of $5 million for $20 million of investments; program runs July 1 to June 30 and expires June 30, 2028. Targeted at accredited angel investors in Connecticut.
• SSBCI Technical Assistance Program A federally funded program (State Small Business Credit Initiative) administered by CI on behalf of the U.S. Treasury to help Socially Economically Disadvantaged Individuals (SEDI) and Very Small Businesses (VSBs) access legal, accounting, or financial advisory services. Targeted at SEDI-owned and Very Small Businesses.
• Human Capital Services (HCS) / Talent Acquisition CI supports portfolio companies with talent acquisition, including planning and strategy, organizational design, university recruiting, compliance, talent segmentation and retention, employer branding, compensation benchmarking, and full-cycle recruitment support. Targeted at CI portfolio companies needing talent acquisition support.
• VentureClash A global venture challenge and investment competition operated by Connecticut Innovations to identify and back early-stage companies across multiple regions (e.g., Tel Aviv, Lagos). Targeted at international and domestic early-stage companies.
• Mission BioCapital 2026 Platinum Program Partnership CI partnership with Mission BioCapital's 2026 Platinum Program supporting early-stage biotech startups with up to $500,000 in pre-seed capital, lab space, and strategic services. Targeted at early-stage biotech startup founders.

Quantifiable outcome

• Generated approximately $41 million in proceeds in Q2 FY26, largely from Halda Therapeutics acquisition by J&J for $3.05 billion
• +2 more outcomes

Named customers10 records

Segments7 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators20 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• New York Ventures (Empire State Development): New York State's quasi-public venture investment arm under Empire State Development. Highly comparable as a state-backed VC deploying capital into in-state startups with co-investment requirements, mission-driven mandate, and thematic fund structures similar to Connecticut Innovations.
• Ben Franklin Technology Partners: Pennsylvania's state-funded, mission-driven VC/seed investor. Operates multiple regional centers funding early-stage technology and life-science companies, with evergreen-style reinvestment structures and operating support analogous to Connecticut Innovations' CBIF and ClimateTech Fund.
• TEDCO (Maryland Technology Development Corporation): Maryland's quasi-public technology economic development corporation. Operates multiple thematic seed and venture funds (similar to CI's CBIF/ClimateTech/AI/Future Fund), invests in in-state early-stage companies, and provides ecosystem programming — directly mirroring Connecticut Innovations' structure and mandate.
• MassTech Collaborative (Massachusetts Technology Collaborative): Massachusetts' quasi-public economic development agency running venture and growth programs like the Massachusetts Growth Capital Corporation and Innovation Voucher program. Directly comparable as a New England state-backed innovation investor with sector-focused funds and operational support services.
• Ohio Third Frontier: Ohio's state-funded technology-based economic development program investing in startup, early-stage, and commercialization capital. Comparable as a multi-fund state venture program with sector specialization, university partnerships, and mission-driven deployment.
• Illinois Ventures: Illinois' state-affiliated venture capital firm investing in technology and life-sciences startups. Operates as a fund-of-funds and direct investor with thematic exposure (similar to CI's CBIF) and is directly comparable as a state-affiliated VC firm.
• In-Q-Tel: Federally chartered, non-profit venture capital firm investing in companies with technologies relevant to U.S. national security. Functionally the most structurally similar organization to Connecticut Innovations — a non-LP-driven VC with mission-aligned mandate, evergreen deployment, and emphasis on emerging technology (AI/quantum). Comparable as a quasi-public VC.
• LaunchTN (Tennessee Technology Development Corporation): Tennessee's state-affiliated organization supporting entrepreneur-led economic development through funding programs, founder networks, and venture deployment. Directly comparable to Connecticut Innovations in mission, structure, and state-backed deployment model.
• NJ Economic Development Authority (NJEDA) Venture Programs: New Jersey's state economic development authority running venture and technology investment programs. Operates thematic funds and direct investment vehicles for in-state startups, analogous to Connecticut Innovations' multi-fund structure and economic-development mission.

Regional players

• Pennsylvania Treasury Venture Capital Program: Pennsylvania's state-managed venture capital deployment program. Operates as a state-owned VC similar to Connecticut Innovations, focusing on in-state economic development via early-stage technology investment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/ct_innovations
• Xx.com/CT_Innovate
• Facebookfacebook.com/6350331965
• LinkedInlinkedin.com/company/67435

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments368 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Connecticut Innovations